EnClear Therapies

medical devices

About

EnClear Therapies is a private medical technology company based in Newburyport, Massachusetts, founded in 2018. The company focuses on developing innovative device-based therapies to enhance the lives of patients with central nervous system (CNS) diseases. Its primary product is the EnTrega CSF Platform, which allows for controlled and personalized delivery of drugs directly to cerebrospinal fluid (CSF), targeting affected areas of the CNS more effectively. The EnTrega CSF Platform is a closed-loop system that integrates machine learning and artificial intelligence to manage CSF flow and drug delivery. It features two access points and a precision pump to regulate drug infusion parameters, optimizing therapeutic effects while minimizing side effects. EnClear Therapies initially targets neuro-oncology, specifically patients with Leptomeningeal Carcinomatosis, and aims to expand its applications to neurodegenerative diseases and other CNS conditions. The company has garnered investment from prominent venture capital firms and collaborates on NIH-funded research projects to advance its technology.

Technologies

Gmail Google Apps Google Cloud Hosting Varnish Mobile Friendly Wix Remote

Keywords

als psp therapies neurodegenerative disease biotech medical device alzheimer drug delivery blood-brain barrier crossing lysosomal storage treatment neurodegenerative diseases csf platform patient care integrated platform drug efficacy optimization healthcare aav vectors neuro-oncology ml/ai in healthcare patient-focused solutions cns disease treatment next-generation therapeutics personalized cns treatment biomedical research ml/ai monitoring local infusion centers neuro-oncology pipeline medical technology clinical development neurotherapeutics

Location

3 65th St, Newburyport, Massachusetts, United States, 01950

Related Companies

Companies in the same industry